Clinical Dermatology Review

REVIEW ARTICLE
Year
: 2021  |  Volume : 5  |  Issue : 2  |  Page : 139--143

COVID-19 vaccination in India: Clinical guidance for patients with dermatological diseases


Namitha Chathra1, Savitha Somaiah2 
1 Department of Dermatology, PES Institute of Medical Science and Research, Kuppam, Andhra Pradesh, India
2 Department of Dermatology, Sapthagiri Institute of Medical Sciences & Research Centre, Bengaluru, Karnataka, India

Correspondence Address:
Namitha Chathra
Department of DVL, PES Institute of Medical Science and Research, Kuppam, Andhra Pradesh
India

Since the advent of COVID-19 vaccines, dermatologists have frequently come across patients, especially those receiving immunomodulatory drugs, who express concerns about the safety and efficacy of vaccines. In this review, we aim to provide guidelines to dermatologists with regard to the three COVID-19 vaccines licensed for use in India. All dermatology patients, even the ones on immunomodulatory drugs, need to be encouraged to take the vaccine. COVID-19 vaccines are not contraindicated in individuals afflicted with eczema; atopic dermatitis; psoriasis; vitiligo; lichen planus; urticaria; connective tissue disorders; and bacterial, mycobacterial, viral, or fungal infections. However, those who have been seriously ill requiring hospitalization are advised to wait for 4–8 weeks. For patients on immunomodulatory drugs, when the disease is stable, the drug may be withheld or dosage reduced for 1–2 weeks following vaccination. However, the vaccination may be given without any modification in the drug/biological. People with a history of anaphylaxis/urticaria can receive a COVID-19 vaccine with 30 min postvaccination observation period. Absolute contraindications include a history of immediate hypersensitivity to any component of the vaccination and hypersensitivity following first dose of vaccination. Patients who have received vaccination can undergo procedures such as skin biopsy, cautery, cryotherapy, lasers, chemical peels, excisions, biopsy, and hair transplantation; fillers may be scheduled 2 weeks before or after the vaccination.


How to cite this article:
Chathra N, Somaiah S. COVID-19 vaccination in India: Clinical guidance for patients with dermatological diseases.Clin Dermatol Rev 2021;5:139-143


How to cite this URL:
Chathra N, Somaiah S. COVID-19 vaccination in India: Clinical guidance for patients with dermatological diseases. Clin Dermatol Rev [serial online] 2021 [cited 2021 Nov 27 ];5:139-143
Available from: https://www.cdriadvlkn.org/article.asp?issn=2542-551X;year=2021;volume=5;issue=2;spage=139;epage=143;aulast=Chathra;type=0